We think it might. Encounter is a cross-domain research & design practice working on Persistence Dynamics: the structural conditions under which living systems persist. Cells, populations, organisations, change programs, the cycles we live inside. We try to find the right intervention when one of them has stalled.
Most of our current evidence is in biology, where the measurements are sharp. The framework reaches further.
What we found
How do cells decide to live, divide, kill, or surrender?
What does it take for a population to renew itself under pressure — and what fails first when it can't?
What is the shape of the menstrual cycle, and why does menopause happen the way it does?
Why do some organizations renew themselves, and others quietly collapse from the inside?
Most change efforts fail to complete. What does it take for a change to land — and what stage does it usually fail at?
What shape does a technology run as, and what does it do to ours?

Most patients given a checkpoint inhibitor do not respond. In a measurable subset the response is not absent but stalled, the T cells built and held in the lymph node. A frozen signature finds them across three cancers, and points to a lever and a test that needs no new patient.

A pre-registered, falsifiable trial-arm proposal: a CD40 agonist plus anti-PD-1 in MSS colorectal selected for the Garrison signature — built CD8 effectors held in the draining node — with the neoadjuvant pCR benefit predicted to concentrate in signature-positive patients.

Ficerafusp alfa pairs deep and durable responses in HPV-negative head and neck. A structural read of why the two arrive together, a dated below-even call on the trial that decides Bicara, and the stratification nobody has put on the table.

Many checkpoint non-responders have already built the T cells that should kill the tumour. The cells never left the lymph node. This is how to find them, and the lever that fits.

RAS proved you have to match the lever to the lesion. The immune cycle has the same logic — and one coordinate, the egress barrier, that nobody has claimed.
Get in touch.